SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ligand (LGND) Breakout!
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
32384 154 0 LGND
Emcee:  Henry Niman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
31559Nigel, yes, I knew the RP royalties applied to only the 3 products (plus a smallfred hayes-3/29/2005
31558Monday the drop. Tuesday/Wednesday the sell off. Margin covering. Wednesday nighdavid nordic-3/29/2005
31557New PR just out...CC tomorrow on Avinza data...Arthur Radley-3/29/2005
31556I'm rooting for someone to buy them. The management has zero credibility, tnigel bates-3/29/2005
31555<i>Again from the 10Q</i> We are currently involved in the researchnigel bates-3/29/2005
31554let me know when they reprice the optionsMadharry-3/29/2005
31553<i>Actually, the recent Glaxo announcement is worth reposting in full...&lnigel bates-3/29/2005
31552You can't believe anything Robinson says. I wouldn't be surprised if thMichael Young-3/29/2005
31551The recent RP deal related only to <b>three</b> Pfizer and Wyeth comnigel bates-3/29/2005
31550FWIW - I joined the LGND longs this afternoon. ijIRWIN JAMES FRANKEL-3/29/2005
31549Thanks david. So the 3 percent is net after paying off RP. I was hoping for somefred hayes-3/29/2005
31548PFE total deal was 6% on lasofoxifene in which lgnde sold off 1/2 half to RP. Sodavid nordic-3/29/2005
31547Looks like non issue or, more likely, I just don't understand what's goifred hayes-3/29/2005
315463% lasofoxifene and market size is 5.7B PFE should get about 1-2B / lgnd about 3david nordic-3/29/2005
31545Nigel, royalty pharma numbers: I make it 3.0125 percent, which is the 1.3875 perfred hayes-3/29/2005
31544kadian reps been on cafepharma board indicating avinza trial will not show positbiostruggle-3/29/2005
31543Targretin NSCLC - Re listen to conference call. Robinson said yesterday that Lipdavid nordic-3/29/2005
31542<i> would have to say the risks are much larger than the rewards. </i&gnigel bates-3/29/2005
31541Lgnd did not file for a 10 day extension thus a delisting may come. In both confdavid nordic-3/29/2005
31540If you assume Robinson will continue to burn money in the NLSC Targretin trials,biostruggle-3/29/2005
31539The delay in filing financial statements puts them in danger of delisting.tom pope-3/29/2005
31538Do you know why?SPSEIFERT-3/29/2005
31537Just checked with Schwab, it remains marginable there as long as it stays above tom pope-3/29/2005
31536Yes, thanks, David. With the accounting issues, it's already non marginable tom pope-3/29/2005
31535Anyone working on a breakup value (they've got to be worth a fair bit more wnigel bates-3/29/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News